<?xml version="1.0" encoding="UTF-8"?><profile href="/about_us/FacultyDirectory/MicrobiologyBiochemistryImmunology/JamesLillard/index.php">
   <image><img src="/about_us/FacultyDirectory/MicrobiologyBiochemistryImmunology/images/JamesLillard.jpg" alt="James W. Lillard"></img></image>
   <name>James W. Lillard, PhD, MBA</name>
   <title>Senior Associate Dean</title>
   <department>Research, Innovation and Commercialization</department>
   <email>jlillard@msm.edu</email>
   <title2>Professor</title2>
   <department2>Microbiology, Biochemistry &amp; Immunology</department2>
   <phone>(404) 752-1863</phone>
   <location>Hugh Gloster Building, Room 340</location>
   <education>
      <p><strong>GRADUATE:</strong><br></br>University of Kentucky College of Medicine<br></br><strong>Degree: </strong>Doctor of Philosophy in Microbiology &amp; Immunology <br></br><br></br>Emory University Goizueta Business School<br></br><strong>Degree: </strong>Master of Business Administration in Healthcare Track<br></br><strong><br></br>UNDERGRADUATE:</strong><br></br>Ohio State University<br></br><strong>Degree: </strong>Bachelor of Science in Electrical &amp; Computer Science Engineering </p>
   </education>
   <research>
      <p>Dr. Lillard is an immunologist who uses both <em>in silico</em> and <em>in vivo</em> methods to develop biologics or molecular tests to better treat or diagnose, respectively,
         chronic diseases. His research involves dissecting the molecular mechanisms of cancer
         and inflammatory diseases, using clinically annotated NGS and real-world data for
         the implementation of precision medicine. His research contributions span disciplines
         including oncology, immunity, inflammation and biodefense. Dr. Lillard’s cumulative
         peer-reviewed funding principally directed over his scientific career exceeds $120
         million and he has authored over 300 scientific communications, which have been <a href="https://scholar.google.com/citations?user=DXLryBwAAAAJ&amp;hl=en">cited over 13,500 times</a>.</p>
   </research>
   <boardcerts></boardcerts>
   <publications>
      <ul>
         <li>M.L. Churchman, X. Lu, D.M. McKean, M.D. Radmacher, Q. Zhang, R.J. Rounbehler, A.C.
            Tan, T.I. Shaw, A. Obermayer, G.D. Grass, D. Spakowicz, A.A. Tarhini, K.H. Shain,
            R.R. Canevarolo, M.B. Meads, A.S. Silva, P.R. Sudalagunta, B.J. Manley, S. Huntsman,
            D. Collyar, J.M. Kolesar, B.M. Evers, N. Single, S.B. Edge, C.S. Johnson, G.J. Weiner,
            M.D. McCarter, V.F. Borges, L. Horne, <strong>J.W. Lillard, Jr</strong>, D.P. Mudaranthakam, J. White, S. Libutti, S. Ganesan, G.M. Riedlinger, T.P. Loughran
            Jr, D.G. Halme, M.A. Johns, C. Arciero, B. Salhia, A.R. Naqash, C.D. Shriver, K.P.
            Lee, B.P. Schneider, D.A. Nix, G.C. Fillmore, H. Colman, C.M. Ulrich, B.C. Springer,
            R. Pollock, E.A. Vucic, J. Sherman, A.K. Jain, W.S. Dalton, P. Agius, and E.M. Siegel.
            2026. The Oncology Research Information Exchange Network (ORIEN) - Building a Real-World
            Collaborative, Patient-driven Infrastructure for Discovery Research and Precision
            Oncology. Res Sq 2:7077810. <a href="https://pubmed.ncbi.nlm.nih.gov/42281974/">PMID: 42281974</a>.</li>
         <li>S. Susalka, <strong>J. Lillard</strong>, T. Litvin-Vechnyak, S. Nappi, and K. Porter. 2025. Cultivating Innovation, Developing
            an Ecosystem for Innovation and Entrepreneurship, and Providing a Support System for
            Technology Transfer. <em>Technology Innovation</em> 24:198-203. <a href="https://doi.org/10.1080/19498241.2025.2565872">https://doi.org/10.1080/19498241.2025.2565872</a></li>
         <li>A. Awai, E.L. Johnson, T. Leng, J. Patrickson, M.C. Zody, H. Phatnani, and <strong>J.W. Lillard, Jr</strong>.<strong></strong>2025. Stratifying ALS Patients by Mode of Inheritance Reveals Transcriptomic Signatures
            Specific to sALS and fALS. <em>Int J Mol Sciences</em> 26:9234<em>. </em><a href="https://pubmed.ncbi.nlm.nih.gov/41009796/">PMID: 410009796</a></li>
         <li>C.D. Young, K.M. Carey, C.D. Dill, S.K. Nunez, T.L. Griffen, E.B. Dammer, and <strong>J.W. Lillard, Jr. </strong>2025. Integrated Systems Biology Reveals an 8-Gene Signature Predicting Early-stage
            Lung Adenocarcinoma Progression and Patient Survival. <em>Scientific Reports</em> 15:34762<em>.</em><a href="https://pubmed.ncbi.nlm.nih.gov/41053230/">PMID: 41053230</a></li>
         <li>S.K. Nunez, C.D. Young, T.L. Griffen, A.Q. Ohandjo, L.P. McKinney, S. Kopetz, and <strong>J.W. Lillard, Jr</strong>. 2021. Identification of Gene Co-Expression Networks Associated with Consensus Molecular
            Subtype-1 of Colorectal Cancer. <em>Cancers</em> <a href="https://pubmed.ncbi.nlm.nih.gov/34830978/">PMID: 34830978</a></li>
         <li>K.M. Carey, C.D. Young, A.J. Clark, E.B. Dammer, R. Singh, and <strong>J.W. Lillard, Jr</strong>. 2024. Subtype-Specific Analysis of Gene Co-expression Networks and Immune Cell Profiling
            Reveals High Grade Serous Ovarian Cancer Subtype Linkage to Variable Immune Microenvironment.
            <em>J Ovarian Cancer </em>17:240. <a href="https://pubmed.ncbi.nlm.nih.gov/39627836/">PMID: 39627836</a></li>
         <li>A. J. Clark, R. Singh, R.L. Leonis, E.A. Stahlberg, Z.S. Clark, and <strong>J.W. Lillard, Jr</strong><strong><sup>x</sup></strong>. 2024. Gene Co-Expression Network Analysis Associated with Endometrial Cancer Tumorigenesis
            and Survival Outcomes. <em>Int J Mol Sciences</em> 25:12356. <a href="https://pubmed.ncbi.nlm.nih.gov/39596419/">PMID: 39596419</a></li>
         <li>R. Fairley, <strong>J.W. Lillard, Jr.</strong>, A. Berk, S. Cornew, J. Gaspero, J. Gillespie, L.L. Horne, S. Kidane, S.B. Munro,
            M. Parsons, E.R. Powers, S.E. Rizzo, A. Tishcler, H. Wohl, and M.C. Weiss. 2023. Increasing
            Clinical Trial Participation of Black Women Diagnosed with Breast Cancer. <em>J Racial Ethn Health Disparities </em><a href="https://pubmed.ncbi.nlm.nih.gov/37314691/">PMID: 37314691</a></li>
         <li><strong>J.W. Lillard, Jr</strong>., K.A. Moses, B.A. Mahal, and D.J. George. 2022. Racial disparities in Black men
            with prostate cancer. <em>Cancer </em><a href="https://pubmed.ncbi.nlm.nih.gov/36066378/">PMID: 36066378</a></li>
         <li>O.O. Adebayo, E.B. Dammer, C.D. Dill, A.O. Adebayo, S.O. Oseni, T.L. Griffen, A.Q.
            Ohandjo, S. Jain, B.G. Barwick, R. Singh, L.H. Boise, and <strong>J.W. Lillard, Jr</strong>. 2022. Multivariant Transcriptome Analysis Identifies Modules and Hub Genes Associated
            with Poor Outcomes in Newly Diagnosed Multiple Myeloma Patients. <em>Cancers</em><a href="https://pubmed.ncbi.nlm.nih.gov/35565356/">PMID: 35565356</a></li>
         <li>T.L. Griffen, F.W. Hoff, Y. Qiu, <strong>J.W. Lillard, Jr</strong>., A. Ferrajoli, P. Thompson, E. Toro, K. Ruiz, J. Burger, W. Wierda, and S.M. Kornblau.
            2022. Proteomic profiling-based classification of CLL provides prognostication for
            modern therapy and identifies novel therapeutic targets. <em>Blood Cancer </em><a href="https://pubmed.ncbi.nlm.nih.gov/35301276/">PMID: 35301276</a></li>
         <li>S.K. Nunez, C.D. Young, T.L. Griffen, A.Q. Ohandjo, L.P. McKinney, S. Kopetz, and
            <strong>J.W. Lillard, Jr</strong>. 2021. Identification of Gene Co-Expression Networks Associated with Consensus Molecular
            Subtype-1 of Colorectal Cancer. <em>Cancers</em><a href="https://pubmed.ncbi.nlm.nih.gov/34830978/">PMID: 34830978</a></li>
         <li>A.P. Howard, L.S. Slaughter, K.M. Carey, and <strong>J.W. Lillard, Jr</strong>. 2021. Bridges to biotechnology and bioentrepreneurship: improving diversity in the
            biotechnology sector. <em>Nature Biotech </em><a href="https://pubmed.ncbi.nlm.nih.gov/34754115/">PMID: 34754115</a></li>
         <li>T.L. Griffen, E. Dammer, C.D. Dill, K.M. Carey, C. Young, S.K. Nunez, and <strong>J.W. Lillard Jr</strong>. 2021. Multivariate transcriptome analysis identifies networks and key drivers of
            chronic lymphocytic leukemia relapse risk and patient survival. <em>BMC Med Genomics </em><a href="https://pubmed.ncbi.nlm.nih.gov/34187466/">PMID: 34187466</a><br></br><br></br><p>Click <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Lillard+J&amp;sort=date">here</a> to view additional publications.</p>
         </li>
      </ul>
   </publications>
   <awards>
      <ul>
         <li><em>Distinguished Fellow</em> of the American Association of Immunologists</li>
         <li>American Association for the Advancement of Science <em>Fellow</em></li>
         <li>National Academy of Inventors <em>Fellow</em></li>
         <li>Milken Institute, <em>FasterCures Health Equity Advisory Council</em></li>
         <li>Frederick National Laboratory for Cancer Research, <em>Scientific Advisory</em><em>Board Member</em></li>
         <li>Veterans Affairs,<em> </em>National Research Advisory Council<em> Member</em></li>
         <li>National Institutes of Health Center for Scientific Review, <em>Innate Immunity &amp; Inflammation Study Section Member</em></li>
         <li>National Institutes of Health Center for Scientific Review,<em> Cancer Diagnostics &amp; Treatments (CDT) SBIR Peer Review Panel Member</em></li>
         <li>National Institutes of Health Center for Scientific Review, <em>Provocative Questions Special Emphasis Peer Review Panel Member</em></li>
         <li>Georgia Cancer Coalition, <em>Distinguished Cancer Scholar Award</em></li>
         <li>United States Food &amp; Drug Administration Transmissible Spongiform Encephalopathy Advisory
            Panel Member</li>
         <li>Academy of Microbiologist, Microbial Triggers of Chronic Human Illness Colloquium
            Member </li>
         <li>Crohn’s &amp; Colitis Foundation of America Senior Research Scientist Award </li>
      </ul>
   </awards>
</profile>